| Pharmaceutical active ingredients: |
| CarbidopaLevodopa |
| Available forms, composition and doses of Carbidopa; Levodopa: |
| Tablets, Extended Release; Oral; Carbidopa 10 mg; Levodopa 100 mgTablets, Extended Release; Oral; Carbidopa 25 mg; Levodopa 100 mgTablets, Extended Release; Oral; Carbidopa 25 mg; Levodopa 250 mgTablets, Extended Release; Oral; Carbidopa 50 mg; Levodopa 200 mgTablets; Oral; Carbidopa 10 mg; Levodopa 100 mgTablets; Oral; Carbidopa 25 mg; Levodopa 100 mgTablets; Oral; Carbidopa 25 mg; Levodopa 250 mg |
| Carbidopa; Levodopa medical category: |
| Human:Antiparkinsonian drugsDopamine precursorsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Mylan |